Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Genomics England Announces Appointment of New Chief Scientific Officer
Genomics England today announces the appointment of Professor Matt Brown as the organisation’s new Chief Scientific Officer […]
Verily to Acquire SignalPath, Expanding Company's Clinical Research Capabilities
Verily, an Alphabet company, and SignalPath today announced that they have entered into an agreement […]
AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research
AllStripes, a healthcare technology company dedicated to unlocking treatments for people affected by rare diseases, […]
HealthTech innovator wins James Dyson Award
In the year ending March 2019, 259 people were killed in the UK using a […]
New Study to Test Third COVID-19 Vaccine for People with Weakened Immune Systems
A new clinical trial to determine whether a third dose of vaccine will improve the […]
Q’Apel Medical Launches Armadillo – A New Radial Artery Access Platform to Meet the Needs of Physicians and Patients
Q’Apel Medical, Inc., an innovative neurovascular company specializing in developing and commercializing novel access device […]
Cough Monitoring Smartphone App Incorporated into Year-Long Respiratory Research Trial
Hyfe, a cough monitoring smartphone app and digital diagnostics tool developed by an international team […]
Qure.ai Bags Second FDA Clearance for Brain CT Scan AI
Leading medical image AI provider Qure.ai has announced US FDA 510(k) clearance for its Brain CT quantification […]
McMaster, Sartorius Stedim Biotech Team up to Advance Biomanufacturing Processes with Next-Gen Tech
Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, has entered into a […]
Mirum Pharmaceuticals Appoints Biotechnology Executive William C. Fairey to its Board of Directors
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced the appointment of industry veteran William C. Fairey […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more